Robert L. Zerbe
Independent Chairman & Lead DirectorDr. Robert L. Zerbe, M.D., serves as the Director of Cirius Therapeutics, Inc. since May 2016. Dr. Robert, co-founded QuatRx Pharmaceuticals Company in 2000 and served as its Chief Executive Officer until July 2016 and President since November 2000. Dr. Zerbe has many years of pharmaceutical development experience including general management, global clinical research and development, clinical trial design and management and regulatory affairs. From 1982 to 2000, he held a variety of research and development positions. During 2000, Dr. Zerbe served as Senior Vice President of Global Research and Development and Director of Development Operations at Pfizer Inc. From 1993 to 2000, he served as Senior Vice President of Worldwide Clinical Research and Development at the Parke-Davis Pharmaceutical Research Division of the Warner-Lambert Company and oversaw the successful development programs for Lipitor, Neurontin and other key products; where as he joined Parke-Davis in 1993. From 1982 to 1993, he held a variety of positions of increasing responsibility at Eli Lilly & Company, Inc. including Managing Director of Lilly Research Center U.K. and Vice President of Clinical Investigation and Regulatory Affairs. He served as the President of Pfizer Inc. He held several positions with Pfizer from 1993 to 2000. He has been the Chairman of Vericel Corporation (known as Aastrom Biosciences, Inc). since October 2012 and has been its Lead Director since October 2012. He has been a Director of Metabolex, Inc. since September 30, 2008, QuatRx Pharmaceuticals Company since November 2000 and Lundbeck Research USA, Inc. since February, 2002. He has been an Independent Director of Vericel Corporation since January 2006. He has been a Member of Board of Managers at Metabolic Solutions Development Company, LLC since October 2014. He serves as a Member of the Board of Directors at Edgemont Pharmaceuticals, LLC. He serves as a Director of Biotechnology Industry Organization Emerging Section Governing Body. He serves as a Member of Scientific and Clinical Advisory Board of OncoMed Pharmaceuticals, Inc. He served as a Director of Heron Therapeutics, Inc. from December 2002 to April 18, 2011; Cymabay Therapeutics, Inc. from September 30, 2008 to December 12, 2012; Optimer Pharmaceuticals, Inc. from December 3, 2009 to October 2013; AP Pharma Inc. from December 2002 to April 18, 2011; Maxim Pharmaceuticals Inc. since 2002; Corgentech Inc. since December 2005; and Anesiva, Inc. from November 2005 to December 16, 2008. Dr. Zerbe earned his M.D. at Indiana University in 1975 and did Post-Doctoral Work in Internal Medicine, Endocrinology and Neuroendocrinology at Indiana University and the National Institutes of Mental Health.
Positions
- Company NameVericel CorporationStock CodeVCELPositionIndependent Chairman & Lead DirectorColleagues
- DCDominick C. ColangeloCEO, President & Director
- JAJoseph Anthony MaraCFO & Treasurer
- MHMichael HalpinChief Operating Officer
- SCSean C. FlynnChief Legal Officer
- JMJonathan M. HopperChief Medical Officer
- ALAlan L. RubinoIndependent Director
- HMHeidi M. HagenIndependent Director
- KFKevin F. McLaughlinIndependent Director
